Pharmacological approach for drug repositioning against cardiorenal diseases.

Explore this paper's citation graph

Summary

This review reports that angiotensin II type 1 receptor blockers show receptor-independent effects against reactive oxygen species generation in renal cells and nitrosonifedipine has an antioxidative effect and protects endothelial cells against oxidative stress, and pioglitazone has multiple effects that improve dysfunctions in vascular control regulated by adrenergic and calcitonin gene-related peptide-containing nerves.

Type
review
Published
2017-01-01
Cited by
8
References
35
Access
Open access

Keywords

Medicine, Drug, Cardiorenal syndrome, Pharmacology, Drug development

References

Cited by

Related papers